#ShipHealthcareHoldings

There will be a change in the representative director effective April 1, 2026, and a proposal for election of directors will be submitted at the Annual General Meeting of Shareholders scheduled for June 25, 2026. Appointment of new directors and executive officers has been announced.

For the nine months ended March 2026, net sales were ¥522,415 million (6.1% YoY increase), operating income was ¥14,450 million (4.4% YoY decrease), and net income attributable to owners of parent for the quarter was ¥9,381 million (10.8% YoY decrease).

Ship Healthcare Holdings has reviewed the committee composition of the Nomination and Compensation Advisory Committee and implemented changes effective February 6, 2026.

For the cumulative Q3 period of the fiscal year ending March 2026, net sales were JPY 522,415 million, up 6.1% year-over-year (YoY); operating income was JPY 14,450 million, down 4.4% YoY; and net income attributable to owners of parent was JPY 9,381 million, down 10.8% YoY.